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1. Introduction 
Each of the 4 identical M, 180 000 subunits of 
human ol,-macroglobulin (o,M) contains a reactive 
Glx-residue [ 11, whose y-carboxyl group is estericed 
to the sul~ydryl group of the cysteinyi residue in the 
sequence: 
-Giy-NH-CH-CO-Gly-Glu-NH-CH-CO-Asn-Met- 
LCH,-S-C-CH,-CH,J 
:: ]2,31 
The Glx-residue is located 469 residues from the 
C-terminus of at,M [3]. 
Complement component C3 also contains a reac- 
tive thiol ester [4,5], located in an identical hepta- 
peptide sequence in itsor’chain [6]_ Fo~owinglimited 
proteolysis in the ‘bait’ region of cwzM [2,3] or at that 
site in C3 which generates C3a and C3b [4-61 the 
thiol esters are rapidly cleaved resulting in the appear- 
ance of free sul~yd~l groups 12-61. 
Reaction of azM and C3 with methylamine leads 
to relatively slow cleavage of their thiol esters [2,4-61. 
During this process a stoichiometric amount of 
CHsNH2 is incorporated into the reactive Glx-residue 
to form y-glutamylmethylamide [l-4,6,7]. As a 
result of this reaction the proteinase binding capacity 
of cu,M [ 1,2,8] and the hemolytic activity of C3 
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[4-6] are lost, indicating that the thiol-esterified 
Glx-residues of the two proteins may participate in 
‘acyi transfer’ reactions [ 2,5,6] which could explain 
the formation of apparently covalent olzM-proteinase 
complexes [9--l I] and also the apparently covalent 
attac~ent of C3b to cell membranes ]6,12,13] and 
of C4b to IgG [ 141. The activated (also known as 
nascent), form of C3b is said to exist only transiently 
11% 
Here we show that when the thiol esters in lvzM 
are activated by the complex formation of arzM with 
trypsin, a corresponding short-lived intermediate is 
generated which can react rapidly and covalently with 
methylam~e or putrescine, We also show that either 
TLCK-trypsin or insulin, when present during trypsin- 
induced activation, is incorporated into CQM. 
2. Materials and methods 
Human azM was prepared by Zn’+-affinity chro- 
matography as in ]2]. Bovine trypsin (60% active) 
(Boehringer, Mannheim) was puriEed by affinity 
chromatography using a column of chicken ovomucoid 
(Boehringer) coupled to Sepharose 4B (Pharmacia, 
Uppsala) as in [ 161. The resulting trypsin preparation 
was 88% active. TLCK-trypsin [ 171 was prepared 
from lzsI labelled [ 181 or unlabelled trypsin and was 
freeze-dried after filtration on Sephadex G-25 in 
0.1 M N&HCOa. Porcine insulin (Nordisk Insulin, 
Gentofte) and insulin specifically mono-iodinated 
[ 191 with “‘1 on Tyr-14 of its A-chain (1.5 Ci/pmol) 
were gifts from J. Gliemann and 0. Sonne, University 
of Aarhus. PTI was obtained from Novo (Bagsvzrd). 
The concentration of oczM was determined using 
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Volume 128, number 1 FEBS LETTERS June 1981 
E:& = 9.1 [20] andM, 725 000 [21]. The concen- 
tration of TLCK-trypsin was determined using E!& = 
15.4 and M, 24 000 [22]. The concentration of 
insulin was determined by amino acid analysis. 
[14C]Methylamine was from New England Nuclear 
(Boston MA) (48 Ci/mol) or the Radiochemical 
Centre (Amersham) (53 Ci/mol). [ 1 ,4-14C]Putres- 
tine (122 Ci/mol) was from Amersham. Methyl- 
amine . HCl and putrescine . 2 HCl was from Sigma 
(St Louis MO). A stock solution of cz,M (15.0 PM) 
in 0.05 M Na-phosphate, 0.1 M NaCl (pH 8.0) was 
used. A stock solution of trypsin was in 1 mM HCl 
(CHOM-purified trypsin, active site titre 183 ELM). 
Solutions of TLCK-trypsin (133 PM) and TLCK- 
lz51-trypsin (133 PM) were in 0.1 M Na-phosphate 
(pH 8.0) (buffer A). Solutions of 0.05-I .O M radio- 
labelled methylamine and putrescine were in buffer 
A. The extent of incorporation of “C-labelled meth- 
ylamine and putrescine into o(*M was measured by 
precipitating CY~M with 10% trichloroacetic acid on 
discs of Whatman 3 MM filter paper and removing 
free amine with 5% trichloroacetic acid and ethanol/ 
acetone (1: 1, v/v) [2]. Since the denaturation of a,M 
with trichloroacetic acid also results in complete 
cleavage of any remaining unreacted thiol ester we 
found it necessary to include NH3 as a ‘competing’ 
nucleophile in this assay [2]. 
3. Results and discussion 
At <I mol trypsin/mol CQM, 4 mol SH appear/m01 
trypsin added. Maximally 4 mol SH appear at >2 mol 
trypsin/mol cuzM [ 21. 
To investigate if activation of the thiol ester of 
azM by proteinases generate an ‘acyl transfer’ potential 
as postulated [2,5,6] a,M was activated by incubating 
for 1 min with increasing concentrations of trypsin 
in the presence of [ “C]methylamine or [ 14C] putres- 
tine. Fig.1 shows that the extent of covalent incorpo- 
ration of these two amines into (YAM parallels the 
trypsin-induced appearance of SH-groups [2]. Thus, 
the results show that a,M when activated by pro- 
teinases can react rapidly to covalently incorporate 
primary amines. Despite the inclusion of NH3 in the 
assay mixture the values of methylamine and of 
putrescine incorporated into azM in the absence of 
trypsin were found to be 0.40 and 0.55 mol/mol 
Q~M, respectively. The incorporation of these amines 
at 25 mM in the presence of 1 mol trypsin/mol azM 
was 2.4-2.5 mol/mol a,M;and 2.7-2.9 mol/mol olzM 
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Fig.1. Incorporation ofCH,NH, and putrescine into lu,M at 
different trypsin concentrations. For each point 10 ~1 a,M 
(15.0 PM) was mixed with 5 ~1 CHOM-purified trypsin 
(diluted from 120 PM) and 10 ~1 CH,NH, or putrescine 
(62.5 mM). After incubation for 60 s at room temperature 
25 ~1 1 M NH,HCO, was added. [ol,M] = 6.0 PM; [trypsin] = 
1.5-24 PM; [CH,NH,] or [putrescine] = 25 mM. A 40 ~1 
aliquot was spotted on a filter disc and the cu,M precipitated 
with 10% trichloroacetic acid as in section 2. CH,NH,, (0); 
putrescine (m). 
at 4 mol trypsin/mol (YAM. The amount of CH3NH2 
bound at 100 mM CH,NH* was -3.0 mol/mol ol,M 
at 2 mol trypsin/mol oc,M. At 0.44 mM CH3NH, 
0.3 mol/mol CQM was bound, showing that covalent 
binding may occur even at this, much lower, concen- 
tration of the nucleophile. Thus, the proteinase- 
induced activation of the oc,M-thiol esters apparently 
makes the reactive Glx-residues, which are normally 
available only to slow covalent incorporation of small 
primary amines, e.g., CH3NH2 [l-3], accessible to 
fast covalent incorporation not only of CH3NH2 but 
also of the larger putrescine. This ability for fast 
covalent incorporation of amines turned out to be a 
fleeting activity of the trypsin-activated ol,M which 
decreases rapidly as shown in fig.2, where ol,M was 
first activated with trypsin (2 mol/mol azM) and 
then, after a variable delay of 5-120 s, incubated 
with CH3NH2 for 60 s. However, it is also evident 
from fig.2 that even after 120 s as much as 0.5 mol 
CH3NHJmol (YAM could still be bound covalently. 
In separate experiments we found that at 2 mol 
trypsin bound/m01 cu,M (in the absence of CH,NH,) 
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Fig.2. Incorporation of CH,NH2 into or,M which had been 
activated with trypsin before adding the CH,NH *. To 20 ~1 
cu,M (15.0 &M) 10 ~1 CHOM-pu~fied trypsin (60 gM) was 
added, followed by addition of 20 ~1 “CH,NH, (62.5 mM) 
at a certain time interval after trypsin addition. [ trypsin] = 
12.0 PM; [o,M] = 6.0 PM; [CH,NH,] = 25 mM. The mixtures 
were then incubated for 60 s after which 40 ~1 1 M NH,HCO, 
was added. Then an 80 ~1 aliquot was spotted on a filter 
disc and the o,M precipitated with 10% trichloroacetic acid 
as in section 2. 
-I .3 mol trypsin was bound ‘covalently’ in the sense 
that it was not separated from crZM when the DTT- 
treated, carboxymethylated complex was gel-filtered 
in 6 M guanidine--HCl at pH 8.0 [ 181. When CHaNHs 
was present during trypsin-induced activation of oaM, 
the total amount of trypsin bound was still the same 
2 mol/mol CQM but now only 0.6 mol was bound 
covalently by the same criterion [ 18 1. Those results 
can be rationalized by proposing that on trypsin- 
induced activation the thiol esters of c.yaM are cleaved 
to produce a highly reactive, short-lived intermediate, 
which will react with available nucleophiles, e.g., pro- 
teinase, methylamine, putrescine and probably water, 
leading to covalent incorpora~on of the respective 
nucleophile on the y-carbonyl group of the reactive 
Glx-residue. This short-lived aaM-intermediate is 
apparently the functional equivalent of the nascent 
C3b, as shown [23] to incorporate not only methyl- 
amine but also phenylhydrazine, glucosamine and 
glycerol. It may also be equivalent with the activated 
o’chain of C4b [ 141 which binds IgG. 
To see if proteins other than active proteinases can 
be incorporated into ‘nascent’ cuzM, the experiments 
shown in fig.3 (TLCK-trypsin) and fig.4 (insulin) 
were done. When present during proteinaseinduced 
(trypsin) activation of cvzM 0.45 mol TLCK-trypsinl 
mol arzM was incorporated (0.26 mol covalently by 
the gel-filtration criterion) for 2.14 mol active trypsin/ 
mol CY~M (fig.3). In the insulin case (fig.4) up to 0.32 
mol insulin/mol crZM was incorporated (0.11 mol 
covalently) for 1.61 mol active trypsin/mol CV~M. In
the absence of active trypsin no incorporation of 
either protein was observed. Furthermore, when 
added 2 min after the active trypsin, only 0.07 mol 
TLCK-trypsin/moI tr,M was bound. Thus, TLCK- 
trypsin and insulin, both proteins lacking proteinase 
activity, can be incorporated into oZM, but only by 
its proteinase-activated ‘nascent form. 
Earlier rest&s, e.g. [24J, indicating that a,M could 
bind insulin can now be explained as having been due 
to ongoing partial activation to ‘nascent’ cuzM by active 
proteinases that must have been present because 
serum, not plasma, was used as a source of osM. 
Considering these results it becomes important to 
define the extent of proteolytic activation and thiol- 
mot active trypin/ mol o(zM 
Fig.3. Binding of TLCK-Y-trypsin to ol,M at different con- 
centrations of active trypsin. Each 500 ~1 sample of a,M con- 
taining a 1.77-fold molar excess of TLCK-“‘1-trypsin was 
incubated with active trypsin for 2 min. Trypsin action was 
stopped by adding 100 ~1 PTI (1.54 mM). All samples were 
then subjected to gel chromatography in buffer A (0) on a 
column of Sephacryl S-300 (1 X 94 cm; 4.0 ml/h; 1 .O ml 
fractions). The material from each sample, eluting in the 
position of o/,M (see fig.1 of [ 181) was pooled, precipitated 
with trichloroacetic acid (lo%, w/v), collected, washed with 
ether, redissolved in 1.0 ml buffer B (0.5 M Tris-HCI, 6 M 
guanidine-HCl, pH 8.0), reduced (20 ~1 0.5 M DTT, 1 h) 
alkylated (50 ~10.5 M ICH,CONH2 10 min) then rechro- 
matographed in buffer B on Sephacryl S-300 (1 X 93 cm; 
4.0 ml/h ; 1.3 ml fractions). (0) Represents TLCK-i%trypsin 
remaining bound to ol,M fragments (eluting in tubes 23-33; 
see fig.2 of [ 18]), under these denaturing conditions. 
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Fig.4. Binding of ‘2*I-labelled insulin to a,M at different 
concentrations of insulin. Samples (500 ~1) of a,M contain- 
ing different amounts of ‘2SI-labelled insulin and unlabelled 
insulin were incubated with active trypsin at a 1.61-fold 
molar excess over o,M for 2 min. Following addition of PTI 
the samples were gel chromato~raphed in buffer A. A single 
experiment performed with a reduced, alkylated sample in 
buffer B showed that 0.11 mol insulin A-chain/m01 02M was 
covalently attached to a,M for 2.3 mol insulin added/m01 
or,M. The conditions for gel chromatography were as in fig.3. 
ester cleavage in crzM preparations used in biological 
experiments, particularly studies of cellular uptake 
mechanisms. 
These results further stress the functional relation- 
ship between a,M and C3 recognized in [l-3,5,6]. 
In particular it is striking that both proteins following 
proteolytic activation interact with their respective 
cell surface receptors, resulting in endocytosis of ol,M- 
proteinase complexes f25--271 or opsonisation of 
complexes between C3b and cells [28-301. 
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